Dr. Lily Dara, MD

Dr. Dara practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Dara's NPI, 1639325053, was assigned on August 18, 2008. Dr. Dara graduated from Shahid Beheshti University of Medical Sciences in 2004. Dr. Dara holds California license A106549.

Dr. Dara's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Dara's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Dara is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Dara to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dara practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dara's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dara is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Dara's licenses on file in 2 states: California and Connecticut.

Dmand AI lists colonoscopy among the conditions Dr. Dara treats.

CMS data shows 12 Medicare services from Dr. Dara across 1 procedure code in 2024, for 14 Medicare patients. Medicare paid $1,756 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 14 Medicare patients who saw Dr. Dara in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dara's median patient age at 58, with 56% women.

In 2024, Dr. Dara wrote 23 Medicare Part D claims for 20 patients. 78% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $170 in total drug cost.

Dr. Dara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dara as offering telehealth. CMS counts 15 procedures of colonoscopy by Dr. Dara, more than 44% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Dara in 2024. Dr. Dara's most frequent co-authors are Foluso Olabisi Ademuyiwa, MD, Batul Hamza Al-Zubeidy, MD and Isaac Chan.

CMS Open Payments shows 28 general payments to Dr. Dara from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Intercept Pharmaceuticals, Inc. paid the most, $70,147.

Dr. Dara graduated from Shahid Beheshti University of Medical Sciences in 2004. Dr. Dara is a member of AASLD and AGA.

Dr. Dara is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.